Read More 1 minute read Analyst Ratings What 11 Analyst Ratings Have To Say About Immunovant By Benzinga Insights August 16, 3:00 PM Immunovant (NASDAQ:IMVT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish… IMVT
Read More 1 minute read Analyst Color Analyst Ratings Biotech General Health Care Movers News Price Target Trading Ideas Immunovant’s FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development By Vandana Singh July 18, 2:39 PM Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP), ARGX
Read More 2 minute read Analyst Ratings 9 Analysts Have This to Say About Immunovant By Benzinga Insights July 18, 9:00 AM Over the past 3 months, 9 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. These analysts are… IMVT
Read More 2 minute read Markets Movers News Penny Stocks Pre-Market Outlook Small Cap Trading Ideas Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday’s Pre-Market Session By Lisa Levin July 17, 7:27 AM U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. ABOS
Read More 1 minute read Analyst Ratings HC Wainwright & Co. Maintains Buy Rating for Immunovant: Here’s What You Need To Know By Benzinga Insights May 23, 1:01 PM HC Wainwright & Co. has decided to maintain its Buy rating of Immunovant (NASDAQ:IMVT) and raise its price… IMVT
Read More 1 minute read Analyst Ratings Analyst Expectations for Immunovant’s Future By Benzinga Insights May 23, 11:02 AM Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish… IMVT
Read More 11 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For May 1, 2023 By Benzinga Insights May 1, 11:00 AM Upgrades Telsey Advisory Group upgraded the previous rating for Allbirds Inc (NASDAQ:BIRD) from Market Perform to Outperform. Allbirds… ALHC
Read More 2 minute read Analyst Ratings Analyst Expectations for Immunovant’s Future By Benzinga Insights April 25, 3:00 PM Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish… IMVT
Read More 11 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For March 30, 2023 By Benzinga Insights March 30, 11:00 AM Upgrades For Palisade Bio Inc (NASDAQ:PALI), Maxim Group upgraded the previous rating of Hold to Buy. For the… AMT
Read More 1 minute read Analyst Ratings 7 Analysts Have This to Say About Immunovant By Benzinga Insights March 30, 11:00 AM Analysts have provided the following ratings for Immunovant (NASDAQ:IMVT) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat… IMVT